CureDuchenne Joins Vivli


Applied Clinical Trials

CureDuchenne has announced that they will contribute patient-level clinical data for treating muscular dystrophy to the Vivli platform. The data will supplement existing studies that are available to request on the Vivli platform and be available to other researchers around the world. 

For more information, click here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.